Globe Life Inc. (NYSE:GL - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eleven ratings firms that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $190.44.
Several brokerages recently commented on GL. Jefferies Financial Group raised their target price on Globe Life from $147.00 to $166.00 and gave the company a "hold" rating in a report on Friday, July 10th. Keefe, Bruyette & Woods decreased their price target on Globe Life from $192.00 to $190.00 and set an "outperform" rating for the company in a report on Friday, July 24th. TD Cowen upped their price target on Globe Life from $215.00 to $225.00 and gave the stock a "buy" rating in a report on Wednesday, July 22nd. Morgan Stanley lowered their price objective on shares of Globe Life from $208.00 to $197.00 and set an "overweight" rating for the company in a research report on Monday, October 5th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $181.00 to $201.00 and gave the company an "overweight" rating in a research report on Tuesday, July 21st.
Get Our Latest Stock Report on GL
Insider Activity
In other Globe Life news, CFO Thomas Kalmbach sold 21,000 shares of the business's stock in a transaction on Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the transaction, the chief financial officer owned 50,568 shares in the company, valued at $9,105,274.08. The trade was a 29.34% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Michael Majors sold 37,000 shares of the business's stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total transaction of $6,609,680.00. Following the completion of the transaction, the executive vice president owned 53,518 shares in the company, valued at $9,560,455.52. This represents a 40.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 143,650 shares of company stock valued at $25,793,717 in the last 90 days. Company insiders own 2.11% of the company's stock.
Institutional Trading of Globe Life
Several large investors have recently modified their holdings of the business. Amundi boosted its holdings in Globe Life by 307.4% in the second quarter. Amundi now owns 162,223 shares of the company's stock worth $28,986,000 after purchasing an additional 122,402 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Globe Life during the second quarter worth $4,574,000. Sei Investments Co. lifted its position in shares of Globe Life by 49.1% in the 1st quarter. Sei Investments Co. now owns 71,795 shares of the company's stock worth $9,993,000 after buying an additional 23,632 shares during the last quarter. Bank of America Corp DE bought a new position in shares of Globe Life in the 2nd quarter worth about $121,638,000. Finally, State Street Corp lifted its position in shares of Globe Life by 2.1% in the 2nd quarter. State Street Corp now owns 3,735,409 shares of the company's stock worth $667,443,000 after buying an additional 76,745 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.
Globe Life Trading Up 0.1%
NYSE:GL opened at $164.33 on Monday. The business's 50-day moving average is $173.18 and its two-hundred day moving average is $165.43. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life has a 12 month low of $127.85 and a 12 month high of $191.55. The firm has a market capitalization of $12.63 billion, a PE ratio of 10.91 and a beta of 0.44.
Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts' consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the firm earned $3.05 EPS. The company's revenue for the quarter was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts predict that Globe Life will post 15.70 earnings per share for the current fiscal year.
Globe Life Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date is Monday, October 5th. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. Globe Life's dividend payout ratio is 8.76%.
Globe Life declared that its Board of Directors has authorized a stock repurchase plan on Monday, August 10th that permits the company to repurchase $2.50 billion in shares. This repurchase authorization permits the company to purchase up to 17.7% of its shares through open market purchases. Stock repurchase plans are often a sign that the company's board believes its shares are undervalued.
Globe Life Company Profile
(
Get Free Report)
Globe Life Inc NYSE: GL is an insurance holding company that provides life and supplemental health insurance products to individuals and families in the United States. Its offerings include term and whole life insurance, mortgage protection coverage, accident and supplemental health policies, and Medicare supplement insurance.
The company distributes its products through a network of insurance agencies, independent agents, and direct-to-consumer channels. Its principal insurance businesses include Globe Life and Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, and Family Heritage Life Insurance Company.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.